Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Tashiro M"" wg kryterium: Autor


Tytuł :
Evaluation of Aspergillus -Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.
Autorzy :
Takazono T; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan .; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Ito Y; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Tashiro M; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Nishimura K; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Saijo T; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Yamamoto K; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Imamura Y; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Miyazaki T; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Yanagihara K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Izumikawa K; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Pokaż więcej
Źródło :
Journal of clinical microbiology [J Clin Microbiol] 2019 Apr 26; Vol. 57 (5). Date of Electronic Publication: 2019 Apr 26 (Print Publication: 2019).
Typ publikacji :
Comparative Study; Evaluation Study; Journal Article
MeSH Terms :
Point-of-Care Testing*
Bronchoalveolar Lavage Fluid/*microbiology
Pulmonary Aspergillosis/*diagnosis
Serum/*microbiology
Aged ; Aged, 80 and over ; Antigens, Fungal/immunology ; Aspergillus/genetics ; Capillary Action ; Female ; Humans ; Invasive Pulmonary Aspergillosis/diagnosis ; Male ; Mannans/blood ; Mannans/immunology ; Middle Aged ; Pulmonary Aspergillosis/blood ; Retrospective Studies ; Sensitivity and Specificity ; Serologic Tests/instrumentation ; Serologic Tests/methods
Czasopismo naukowe
Tytuł :
Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.
Autorzy :
Iwata-Yoshikawa N; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Okamura T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Laboratory Animal Medicine, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.; Section of Animal Models, Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Shimizu Y; Department of Laboratory Animal Medicine, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Kotani O; Laboratory of Viral Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Sato H; Laboratory of Viral Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Sekimukai H; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Tissue Physiology, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Fukushi S; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Sato Y; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Takeda M; Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Tashiro M; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hasegawa H; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Nagata N; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan .
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2019 Mar 05; Vol. 93 (6). Date of Electronic Publication: 2019 Mar 05 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Coronavirus Infections/*metabolism
Dipeptidyl Peptidase 4/*metabolism
Lung/*virology
Middle East Respiratory Syndrome Coronavirus/*pathogenicity
Animals ; Cell Line ; Chlorocebus aethiops ; Coronavirus Infections/virology ; Cytokines/metabolism ; Disease Models, Animal ; Female ; Macrophages/metabolism ; Macrophages/virology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Respiratory Tract Infections/metabolism ; Respiratory Tract Infections/virology ; Vero Cells
Czasopismo naukowe
Tytuł :
Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
Autorzy :
Naito T; Department of Microbiology, Kawasaki Medical School, Okayama, Japan -m.ac.jp .
Mori K; Laboratory of Virology, Institute of Microbial Chemistry, Tokyo, Japan.; Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.; Japan Society for the Promotion of Science, Tokyo, Japan.
Ushirogawa H; Department of Microbiology, Kawasaki Medical School, Okayama, Japan.
Takizawa N; Laboratory of Virology, Institute of Microbial Chemistry, Tokyo, Japan.
Nobusawa E; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Odagiri T; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Tashiro M; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Ohniwa RL; Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.; Center for Biotechnology, National Taiwan University, Taipei, Taiwan.
Nagata K; Faculty of Medicine, University of Tsukuba, Ibaraki, Japan -m.ac.jp .
Saito M; Department of Microbiology, Kawasaki Medical School, Okayama, Japan.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2017 Feb 28; Vol. 91 (6). Date of Electronic Publication: 2017 Feb 28 (Print Publication: 2017).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, Viral/*genetics
Influenza A virus/*growth & development
Influenza Vaccines/*immunology
Reassortant Viruses/*growth & development
Amino Acid Substitution ; Antigens, Viral/immunology ; Influenza A virus/genetics ; Influenza Vaccines/genetics ; Point Mutation ; Reassortant Viruses/genetics ; Technology, Pharmaceutical/methods ; Viral Proteins/genetics ; Virology/methods
Czasopismo naukowe
Tytuł :
A mutant H3N2 influenza virus uses an alternative activation mechanism in TMPRSS2 knockout mice by loss of an oligosaccharide in the hemagglutinin stalk region.
Autorzy :
Sakai K; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan .
Sekizuka T; Laboratory of Bacterial Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Ami Y; Division of Experimental Animal Research, National Institute of Infectious Diseases, Tokyo, Japan.
Nakajima N; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Kitazawa M; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan Laboratory of Animal Health, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Sato Y; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Nakajima K; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan Laboratory of Animal Health, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Anraku M; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Kubota T; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Komase K; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Takehara K; Laboratory of Animal Health, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Hasegawa H; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Odagiri T; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Tashiro M; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kuroda M; Laboratory of Bacterial Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Takeda M; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2015 May; Vol. 89 (9), pp. 5154-8. Date of Electronic Publication: 2015 Feb 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Protein Processing, Post-Translational*
Hemagglutinin Glycoproteins, Influenza Virus/*metabolism
Influenza A Virus, H3N2 Subtype/*genetics
Influenza A Virus, H3N2 Subtype/*physiology
Oligosaccharides/*metabolism
Serine Endopeptidases/*deficiency
Animals ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Influenza A Virus, H3N2 Subtype/growth & development ; Mice, Knockout ; Oligosaccharides/genetics ; Virulence ; Virus Internalization
Czasopismo naukowe
Tytuł :
Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan.
Autorzy :
Takashita E; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kiso M; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Fujisaki S; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yokoyama M; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Nakamura K; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Shirakura M; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Sato H; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Odagiri T; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kawaoka Y; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan ERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Tashiro M; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan .
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 May; Vol. 59 (5), pp. 2607-17. Date of Electronic Publication: 2015 Feb 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Viral*/genetics
Antiviral Agents/*pharmacology
Cyclopentanes/*pharmacology
Guanidines/*pharmacology
Influenza A Virus, H1N1 Subtype/*drug effects
Oseltamivir/*pharmacology
Acids, Carbocyclic ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Japan ; Viral Proteins/genetics
Czasopismo naukowe
Tytuł :
Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness.
Autorzy :
Schultz-Cherry S; WHO Collaborating Center for Studies on the Ecology of Influenza in Animals, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA .
Webby RJ; WHO Collaborating Center for Studies on the Ecology of Influenza in Animals, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Webster RG; WHO Collaborating Center for Studies on the Ecology of Influenza in Animals, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Kelso A; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Barr IG; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
McCauley JW; WHO Collaborating Centre for Reference and Research on Influenza, Division of Virology, MRC National Institute for Medical Research, Mill Hill, London, United Kingdom.
Daniels RS; WHO Collaborating Centre for Reference and Research on Influenza, Division of Virology, MRC National Institute for Medical Research, Mill Hill, London, United Kingdom.
Wang D; WHO Collaborating Center for Reference and Research on Influenza, Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention China CDC, Beijing, People's Republic of China.
Shu Y; WHO Collaborating Center for Reference and Research on Influenza, Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention China CDC, Beijing, People's Republic of China.
Nobusawa E; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, Tokyo, Japan.
Itamura S; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, Tokyo, Japan.
Tashiro M; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, Tokyo, Japan.
Harada Y; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, Tokyo, Japan.
Watanabe S; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, Tokyo, Japan.
Odagiri T; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, Tokyo, Japan.
Ye Z; Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA.
Grohmann G; Immunology and Vaccines, Therapeutic Goods Administration Laboratories, Woden, ACT, Australia.
Harvey R; National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Engelhardt O; National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Smith D; Center for Pathogen Evolution, Department of Zoology, WHO CC for Modeling Evolution and Control of Emerging Infectious Diseases, University of Cambridge, Cambridge, United Kingdom.
Hamilton K; OIE Scientific and Technical Department, OIE, Paris, France.
Claes F; OFFLU/EMPRES Laboratory Unit, Animal Health Service, FAO, Rome, Italy.
Dauphin G; OFFLU/EMPRES Laboratory Unit, Animal Health Service, FAO, Rome, Italy.
Pokaż więcej
Źródło :
MBio [mBio] 2014 Dec 12; Vol. 5 (6). Date of Electronic Publication: 2014 Dec 12.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Discovery/*methods
Influenza A virus/*pathogenicity
Influenza Vaccines/*isolation & purification
Influenza in Birds/*virology
Influenza, Human/*prevention & control
Pandemics/*prevention & control
Zoonoses/*prevention & control
Animals ; Humans ; Influenza A virus/genetics ; Influenza A virus/isolation & purification ; Influenza Vaccines/immunology ; Influenza in Birds/transmission ; Influenza, Human/epidemiology ; Influenza, Human/immunology ; Influenza, Human/virology ; Poultry ; Technology, Pharmaceutical/methods ; Zoonoses/epidemiology ; Zoonoses/immunology ; Zoonoses/virology
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies